Mutual Drug Discusses DSCSA Compliance Challenges

Resources

Download PDF
Share
- LinkedIn
- Facebook
- Mail
- Twitter

Wholesale distributor Mutual Drug began making a plan for a DSCSA solution as soon as the law was passed. Hear Andrew Meyer, Senior Systems Analyst & Traceability Lead, discuss their criteria for selecting a compliance partner plus some of the challenges they faced in working towards the May 1 deadline.

<a href="/region-type/united-states" hreflang="en">United States</a>

Mutual Drug Discusses DSCSA Compliance Challenges

Table of contents

Table of contents

Mutual Drug Discusses DSCSA Compliance Challenges

Table of contents

Table of contents

More Serialization and Compliance Resources

Henry Schein: Manufacturers Must Stay Focused on Saleable Returns Verification

Case Study: TraceLink | FDA Pilot - Product Traceability Under 2023 DSCSA Regulations - A Business Process-Led Design for a Blockchain Network

Case Study: TraceLink | Building the TraceLink Network One Business Process Ecosystem at a Time

Managing Serialization Data at the Edge with Edge Track

Turning Point: From Achieving Compliance to Creating Business Value from Serialization

TraceLink: The World's Largest Integrated Digital Supply Network

Cookie Settings